Cargando…
Drug Repurposing in the Treatment of Traumatic Brain Injury
Traumatic brain injury (TBI) is the most common cause of morbidity among trauma patients; however, an effective pharmacological treatment has not yet been approved. Individuals with TBI are at greater risk of developing neurological illnesses such as Alzheimer’s disease (AD) and Parkinson’s disease...
Autores principales: | Ghiam, Michael K., Patel, Shrey D., Hoffer, Alan, Selman, Warren R., Hoffer, Barry J., Hoffer, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021906/ https://www.ncbi.nlm.nih.gov/pubmed/33833663 http://dx.doi.org/10.3389/fnins.2021.635483 |
Ejemplares similares
-
Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine
por: Hoffer, Barry J., et al.
Publicado: (2017) -
Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study
por: Hoffer, Michael E., et al.
Publicado: (2013) -
Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury
por: Eakin, Katharine, et al.
Publicado: (2014) -
(-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and
Behavioral Impairments Induced by Traumatic Brain Injury in Mice
por: Hsueh, Shih-Chang, et al.
Publicado: (2019) -
Mitochondria: A Therapeutic Target for Parkinson’s Disease?
por: Luo, Yu, et al.
Publicado: (2015)